XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Segment Disclosures | 3 Months Ended
--- | ---
Mar. 31, 2017
Segment Disclosures |
Segment Disclosures | NOTE 13. Segment Disclosures The Company evaluates its business and allocates resources based on its reportable business segments: (i) SH NNN, (ii) SHOP, (iii) life science and (iv) medical office. Under the medical office segment, the Company invests through the acquisition and development of MOBs, which generally require a greater level of property management. Otherwise, the Company primarily invests, through the acquisition and development of real estate, in single tenant and operator properties. The Company has non-reportable segments that are comprised primarily of the Company’s debt investments, hospital properties and U.K. care homes. The accounting policies of the segments are the same as those in Note 2 to the Consolidated Financial Statements in the Company’s 2016 Annual Report on Form 10-K filed with the SEC, as amended by Note 2 herein. During the year ended December 31, 2016, 17 SH NNN facilities were transitioned to a RIDEA structure (reported in the Company’s SHOP segment). During the three months ended March 31, 2017, one SH NNN facility was transitioned to a RIDEA structure. The Company evaluates performance based upon: (i) property net operating income from continuing operations (“NOI”) and (ii) adjusted NOI of the combined consolidated and unconsolidated investments in each segment. Non-segment assets consist primarily of corporate assets, including cash and cash equivalents, restricted cash, accounts receivable, net, marketable equity securities and, if any, real estate held for sale. Interest expense, depreciation and amortization, and non-property specific revenues and expenses are not allocated to individual segments in evaluating the Company’s segment-level performance. See Note 17 for other information regarding concentrations of credit risk. The following tables summarize information for the reportable segments (in thousands): For the three months ended March 31, 2017:
|  |  |  |  |  |  | Life |  | Medical |  | Other |  | Corporate |  |
|  |  | SH NNN |  | SHOP |  | Science |  | Office |  | Non-reportable |  | Non-segment |  | Total
| Rental revenues(1) |  | $ | 100,034 |  | $ | 140,228 |  | $ | 85,321 |  | $ | 118,371 |  | $ | 29,883 |  | $ | — |  | $ | 473,837
| HCP share of unconsolidated JV revenues |  |  | — |  |  | 76,364 |  |  | 1,940 |  |  | 489 |  |  | 418 |  |  | — |  |  | 79,211
| Operating expenses |  |  | (1,111) |  |  | (94,539) |  |  | (17,319) |  |  | (44,864) |  |  | (1,248) |  |  | — |  |  | (159,081)
| HCP share of unconsolidated JV operating expenses |  |  | — |  |  | (59,527) |  |  | (371) |  |  | (142) |  |  | (19) |  |  | — |  |  | (60,059)
| NOI |  |  | 98,923 |  |  | 62,526 |  |  | 69,571 |  |  | 73,854 |  |  | 29,034 |  |  | — |  |  | 333,908
| Adjustments to NOI(2) |  |  | (1,839) |  |  | 3,508 |  |  | (256) |  |  | (969) |  |  | (1,012) |  |  | — |  |  | (568)
| Adjusted NOI |  |  | 97,084 |  |  | 66,034 |  |  | 69,315 |  |  | 72,885 |  |  | 28,022 |  |  | — |  |  | 333,340
| Addback adjustments |  |  | 1,839 |  |  | (3,508) |  |  | 256 |  |  | 969 |  |  | 1,012 |  |  | — |  |  | 568
| Interest income |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 18,331 |  |  | — |  |  | 18,331
| Interest expense |  |  | (627) |  |  | (4,596) |  |  | (104) |  |  | (129) |  |  | (1,997) |  |  | (79,265) |  |  | (86,718)
| Depreciation and amortization |  |  | (26,411) |  |  | (26,358) |  |  | (33,791) |  |  | (42,729) |  |  | (7,265) |  |  | — |  |  | (136,554)
| General and administrative |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (22,478) |  |  | (22,478)
| Acquisition and pursuit costs |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1,057) |  |  | (1,057)
| Gain on sales of real estate, net |  |  | 268,464 |  |  | 366 |  |  | 44,633 |  |  | — |  |  | 3,795 |  |  | — |  |  | 317,258
| Other income, net |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 51,208 |  |  | 51,208
| Income tax benefit |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 6,162 |  |  | 6,162
| Less: HCP share of unconsolidated JV NOI |  |  | — |  |  | (16,837) |  |  | (1,569) |  |  | (347) |  |  | (399) |  |  | — |  |  | (19,152)
| Equity income in unconsolidated JVs |  |  | — |  |  | 1,993 |  |  | 770 |  |  | 269 |  |  | 237 |  |  | — |  |  | 3,269
| Net income (loss) |  | $ | 340,349 |  | $ | 17,094 |  | $ | 79,510 |  | $ | 30,918 |  | $ | 41,736 |  | $ | (45,430) |  | $ | 464,177
For the three months ended March 31, 2016:
|  |  |  |  |  |  | Life |  | Medical |  | Other |  | Corporate |  |
|  |  | SH NNN |  | SHOP |  | Science |  | Office |  | Non-reportable |  | Non-segment |  | Total
| Rental revenues(1) |  | $ | 106,889 |  | $ | 165,763 |  | $ | 88,948 |  | $ | 108,023 |  | $ | 32,805 |  | $ | — |  | $ | 502,428
| HCP share of unconsolidated JV revenues |  |  | — |  |  | 52,277 |  |  | 1,810 |  |  | 479 |  |  | 407 |  |  | — |  |  | 54,973
| Operating expenses |  |  | (2,074) |  |  | (114,003) |  |  | (16,743) |  |  | (41,949) |  |  | (1,188) |  |  | — |  |  | (175,957)
| HCP share of unconsolidated JV operating expenses |  |  | — |  |  | (42,088) |  |  | (374) |  |  | (149) |  |  | (3) |  |  | — |  |  | (42,614)
| NOI |  |  | 104,815 |  |  | 61,949 |  |  | 73,641 |  |  | 66,404 |  |  | 32,021 |  |  | — |  |  | 338,830
| Adjustments to NOI(2) |  |  | (5,443) |  |  | 5,032 |  |  | (673) |  |  | (795) |  |  | (571) |  |  | — |  |  | (2,450)
| Adjusted NOI |  |  | 99,372 |  |  | 66,981 |  |  | 72,968 |  |  | 65,609 |  |  | 31,450 |  |  | — |  |  | 336,380
| Addback adjustments |  |  | 5,443 |  |  | (5,032) |  |  | 673 |  |  | 795 |  |  | 571 |  |  | — |  |  | 2,450
| Interest income |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 18,029 |  |  | — |  |  | 18,029
| Interest expense |  |  | (4,166) |  |  | (7,855) |  |  | (638) |  |  | (1,665) |  |  | (2,327) |  |  | (105,411) |  |  | (122,062)
| Depreciation and amortization |  |  | (33,506) |  |  | (26,297) |  |  | (33,596) |  |  | (38,719) |  |  | (7,737) |  |  | — |  |  | (139,855)
| General and administrative |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (25,451) |  |  | (25,451)
| Acquisition and pursuit costs |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (2,475) |  |  | (2,475)
| Other income, net |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,292 |  |  | 1,292
| Income tax expense |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (3,704) |  |  | (3,704)
| Less: HCP share of unconsolidated JV NOI |  |  | — |  |  | (10,189) |  |  | (1,436) |  |  | (330) |  |  | (404) |  |  | — |  |  | (12,359)
| Equity (loss) income in unconsolidated JVs |  |  | — |  |  | (2,478) |  |  | 709 |  |  | 658 |  |  | 203 |  |  | — |  |  | (908)
| Discontinued operations |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 68,408 |  |  | 68,408
| Net income (loss) |  | $ | 67,143 |  | $ | 15,130 |  | $ | 38,680 |  | $ | 26,348 |  | $ | 39,785 |  | $ | (67,341) |  | $ | 119,745
| (1) |  | Represents rental and related revenues, tenant recoveries, resident fees and services, and income from DFLs.
| (2) |  | Represents straight-line rents, DFL non-cash interest, amortization of market lease intangibles, net, lease termination fees and non-refundable entrance fees as the fees are collected by the Company’s CCRC JV, net of CCRC JV entrance fee amortization.
The following table summarizes the Company’s revenues by segment (in thousands):
|  | Three Months Ended March 31,
Segment |  | 2017 |  | 2016
SH NNN |  | $ | 100,034 |  | $ | 106,889
SHOP |  |  | 140,228 |  |  | 165,763
Life science |  |  | 85,321 |  |  | 88,948
Medical office |  |  | 118,371 |  |  | 108,023
Other non-reportable segments |  |  | 48,214 |  |  | 50,834
Total revenues |  | $ | 492,168 |  | $ | 520,457
See Notes 3 and 4 for significant transactions impacting the Company’s segment assets during the periods presented.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration